{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T03:40:22Z","timestamp":1794973222291,"version":"4.9.1"},"reference-count":207,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["U19AG069701"],"award-info":[{"award-number":["U19AG069701"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["U54NS110435"],"award-info":[{"award-number":["U54NS110435"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100012524","name":"American Lebanese Syrian Associated Charities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012524","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The advancements of proteomics technologies are shaping Alzheimer's disease (AD) research, revealing new molecular insights and improving biomarker discovery. Here, we summarize major AD proteomics studies since our 2021 review, focusing on disease mechanisms and biomarker identification. Enhanced sensitivity and throughput in proteome profiling have been driven by mass spectrometry (MS)-based approaches and affinity-based platforms (e.g., Olink and SomaScan). Emerging techniques, including single-cell, spatial, and single-molecule proteomics, provide unprecedented resolution in studying cellular heterogeneity and pathological microenvironments (e.g., amyloidome). Multi-cohort analyses of AD brain tissues have revealed consensus protein alterations (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009866), identifying novel disease-associated proteins validated in functional studies (e.g., MDK\/PTN, NTN1, SMOC1, GPNMB, NPTX2, NRN1, VGF, and U1 snRNP). Proteomic studies of AD biofluids have identified distinct disease subtypes, offering candidate proteins for early detection. Comparisons between human tissues and AD mouse models highlight shared pathways in amyloid pathology while underscoring limitations in recapitulating human disease. Combining proteomics with genomics enables protein quantitative trait locus (pQTL) analysis in AD, linking genetic risk factors to protein expression changes. Discrepancies between proteome and transcriptome suggest altered protein turnover in AD. Overall, AD proteomics continues to provide mechanistic insights into disease progression and potential biomarkers for precision medicine.\n                  <\/jats:p>","DOI":"10.1186\/s13024-025-00874-5","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T08:31:14Z","timestamp":1752481874000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Proteomic landscape of Alzheimer\u2019s disease: emerging technologies, advances and insights (2021 \u2013 2025)"],"prefix":"10.1186","volume":"20","author":[{"given":"Jay M.","family":"Yarbro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Him K.","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masihuz","family":"Zaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqi","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xusheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junmin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,14]]},"reference":[{"key":"874_CR1","doi-asserted-by":"crossref","unstructured":"2024 Alzheimer's disease facts and figures. Alzheimers Dement. 2024;20:3708-3821.","DOI":"10.1002\/alz.13809"},{"key":"874_CR2","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature19323","volume":"537","author":"J Sevigny","year":"2016","unstructured":"Sevigny J, Chiao P, Bussi\u00e8re T, Weinreb PH, Williams L, Maier M, Dunstan R, Salloway S, Chen T, Ling Y. The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease. Nature. 2016;537:50\u20136.","journal-title":"Nature"},{"key":"874_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, Kanekiyo M, Li D, Reyderman L, Cohen S, et al. Lecanemab in early Alzheimer\u2019s disease. N Engl J Med. 2023;388:9\u201321.","journal-title":"N Engl J Med"},{"key":"874_CR4","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","volume":"384","author":"MA Mintun","year":"2021","unstructured":"Mintun MA, Lo AC, Duggan Evans C, Wessels AM, Ardayfio PA, Andersen SW, Shcherbinin S, Sparks J, Sims JR, Brys M. Donanemab in early Alzheimer\u2019s disease. N Engl J Med. 2021;384:1691\u2013704.","journal-title":"N Engl J Med"},{"key":"874_CR5","doi-asserted-by":"publisher","first-page":"797","DOI":"10.2147\/CIA.S325026","volume":"17","author":"M Vaz","year":"2022","unstructured":"Vaz M, Silva V, Monteiro C, Silvestre S. Role of aducanumab in the treatment of Alzheimer\u2019s disease: challenges and opportunities. Clin Interv Aging. 2022;17:797\u2013810.","journal-title":"Clin Interv Aging"},{"key":"874_CR6","doi-asserted-by":"publisher","first-page":"943","DOI":"10.17219\/acem\/171379","volume":"32","author":"M Kurkinen","year":"2023","unstructured":"Kurkinen M. Lecanemab (Leqembi) is not the right drug for patients with Alzheimer\u2019s disease. Adv Clin Exp Med. 2023;32:943\u20137.","journal-title":"Adv Clin Exp Med"},{"key":"874_CR7","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1001\/jama.2023.11704","volume":"330","author":"JJ Manly","year":"2023","unstructured":"Manly JJ, Deters KD. Donanemab for Alzheimer disease\u2014who benefits and who is harmed? JAMA. 2023;330:510\u20131.","journal-title":"JAMA"},{"key":"874_CR8","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA. Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science. 1992;256:184\u20135.","journal-title":"Science"},{"key":"874_CR9","doi-asserted-by":"crossref","unstructured":"Aisen P, Bateman RJ, Crowther D, Cummings J, Dwyer J, Iwatsubo T, Kosco-Vilbois M, McDade E, Mohs R, Scheltens P, et al. The case for regulatory approval of amyloid-lowering immunotherapies in Alzheimer's disease based on clearcut biomarker evidence. Alzheimers Dement. 2025;21:e14342.","DOI":"10.1002\/alz.14342"},{"key":"874_CR10","doi-asserted-by":"publisher","first-page":"3969","DOI":"10.1093\/brain\/awad159","volume":"146","author":"KP Kepp","year":"2023","unstructured":"Kepp KP, Robakis NK, H\u00f8ilund-Carlsen PF, Sensi SL, Vissel B. The amyloid cascade hypothesis: an updated critical review. Brain. 2023;146:3969\u201390.","journal-title":"Brain"},{"key":"874_CR11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA DeTure","year":"2019","unstructured":"DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer\u2019s disease. Mol Neurodegener. 2019;14:32.","journal-title":"Mol Neurodegener"},{"key":"874_CR12","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00401-017-1717-7","volume":"134","author":"A Kapasi","year":"2017","unstructured":"Kapasi A, DeCarli C, Schneider JA. Impact of multiple pathologies on the threshold for clinically overt dementia. Acta Neuropathol. 2017;134:171\u201386.","journal-title":"Acta Neuropathol"},{"key":"874_CR13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/ana.25123","volume":"83","author":"PA Boyle","year":"2018","unstructured":"Boyle PA, Yu L, Wilson RS, Leurgans SE, Schneider JA, Bennett DA. Person-specific contribution of neuropathologies to cognitive loss in old age. Ann Neurol. 2018;83:74\u201383.","journal-title":"Ann Neurol"},{"key":"874_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1146\/annurev-bioeng-061008-124934","volume":"11","author":"JR Yates","year":"2009","unstructured":"Yates JR, Ruse CI, Nakorchevsky A. Proteomics by mass spectrometry: approaches, advances, and applications. Annu Rev Biomed Eng. 2009;11:49\u201379.","journal-title":"Annu Rev Biomed Eng"},{"key":"874_CR15","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nature19949","volume":"537","author":"R Aebersold","year":"2016","unstructured":"Aebersold R, Mann M. Mass-spectrometric exploration of proteome structure and function. Nature. 2016;537:347\u201355.","journal-title":"Nature"},{"key":"874_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13024-021-00474-z","volume":"16","author":"B Bai","year":"2021","unstructured":"Bai B, Vanderwall D, Li Y, Wang X, Poudel S, Wang H, Dey KK, Chen PC, Yang K, Peng J. Proteomic landscape of Alzheimer\u2019s disease: novel insights into pathogenesis and biomarker discovery. Mol Neurodegener. 2021;16:55.","journal-title":"Mol Neurodegener"},{"key":"874_CR17","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.neuron.2019.12.015","volume":"105","author":"B Bai","year":"2020","unstructured":"Bai B, Wang X, Li Y, Chen PC, Yu K, Dey KK, Yarbro JM, Han X, Lutz BM, Rao S, et al. Deep multilayer brain proteomics identifies molecular networks in Alzheimer\u2019s disease progression. Neuron. 2020;105:975\u201391.","journal-title":"Neuron"},{"key":"874_CR18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41593-021-00999-y","volume":"25","author":"ECB Johnson","year":"2022","unstructured":"Johnson ECB, Carter EK, Dammer EB, Duong DM, Gerasimov ES, Liu Y, Liu J, Betarbet R, Ping L, Yin L, et al. Large-scale deep multi-layer analysis of Alzheimer\u2019s disease brain reveals strong proteomic disease-related changes not observed at the RNA level. Nat Neurosci. 2022;25:213\u201325.","journal-title":"Nat Neurosci"},{"key":"874_CR19","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1038\/s41591-023-02476-4","volume":"29","author":"ECB Johnson","year":"2023","unstructured":"Johnson ECB, Bian S, Haque RU, Carter EK, Watson CM, Gordon BA, Ping L, Duong DM, Epstein MP, McDade E, et al. Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer\u2019s disease. Nat Med. 2023;29:1979\u201388.","journal-title":"Nat Med"},{"key":"874_CR20","doi-asserted-by":"publisher","first-page":"4466","DOI":"10.1038\/s41467-023-40208-x","volume":"14","author":"M Askenazi","year":"2023","unstructured":"Askenazi M, Kavanagh T, Pires G, Ueberheide B, Wisniewski T, Drummond E. Compilation of reported protein changes in the brain in Alzheimer\u2019s disease. Nat Commun. 2023;14:4466.","journal-title":"Nat Commun"},{"key":"874_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40478-022-01356-1","volume":"10","author":"E Drummond","year":"2022","unstructured":"Drummond E, Kavanagh T, Pires G, Marta-Ariza M, Kanshin E, Nayak S, Faustin A, Berdah V, Ueberheide B, Wisniewski T. The amyloid plaque proteome in early onset Alzheimer\u2019s disease and down syndrome. Acta Neuropathol Commun. 2022;10:53.","journal-title":"Acta Neuropathol Commun"},{"key":"874_CR22","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1038\/s41593-024-01737-w","volume":"27","author":"A Pichet Binette","year":"2024","unstructured":"Pichet Binette A, Gaiteri C, Wennstrom M, Kumar A, Hristovska I, Spotorno N, Salvado G, Strandberg O, Mathys H, Tsai LH, et al. Proteomic changes in Alzheimer\u2019s disease associated with progressive abeta plaque and tau tangle pathologies. Nat Neurosci. 2024;27:1880\u201391.","journal-title":"Nat Neurosci"},{"key":"874_CR23","doi-asserted-by":"publisher","first-page":"1363\u20131379","DOI":"10.1016\/j.neuron.2025.02.014","volume":"113","author":"M Ali","year":"2025","unstructured":"Ali M, Timsina J, Western D, Liu M, Beric A, Budde J, Do A, Heo G, Wang L, Gentsch J, et al. Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures across the Alzheimer disease continuum. Neuron. 2025;113:1363-1379-e1369.","journal-title":"Neuron"},{"key":"874_CR24","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/s41467-025-56853-3","volume":"16","author":"JM Yarbro","year":"2025","unstructured":"Yarbro JM, Han X, Dasgupta A, Yang K, Liu D, Shrestha HK, Zaman M, Wang Z, Yu K, Lee DG, et al. Human and mouse proteomics reveals the shared pathways in Alzheimer\u2019s disease and delayed protein turnover in the amyloidome. Nat Commun. 2025;16:1533.","journal-title":"Nat Commun"},{"key":"874_CR25","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13024-022-00572-6","volume":"17","author":"T Kavanagh","year":"2022","unstructured":"Kavanagh T, Halder A, Drummond E. Tau interactome and RNA binding proteins in neurodegenerative diseases. Mol Neurodegener. 2022;17:66.","journal-title":"Mol Neurodegener"},{"key":"874_CR26","doi-asserted-by":"publisher","unstructured":"Shrestha H, et al. Pan-neurodegeneration proteomics reveals disease subtypes and molecular signatures in six neurodegenerative disorders. Sneak Peek. 2025. https:\/\/doi.org\/10.2139\/ssrn.5245669.","DOI":"10.2139\/ssrn.5245669"},{"key":"874_CR27","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1021\/ac0262560","volume":"75","author":"A Thompson","year":"2003","unstructured":"Thompson A, Sch\u00e4fer J, Kuhn K, Kienle S, Schwarz J, Schmidt G, Neumann T, Johnstone R, Mohammed AK, Hamon C. Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS\/MS. Anal Chem. 2003;75:1895\u2013904.","journal-title":"Anal Chem"},{"key":"874_CR28","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/nmeth.2193","volume":"9","author":"A Doerr","year":"2012","unstructured":"Doerr A. Targeting with PRM. Nat Methods. 2012;9:950\u2013950.","journal-title":"Nat Methods"},{"key":"874_CR29","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1074\/mcp.O112.020131","volume":"11","author":"AC Peterson","year":"2012","unstructured":"Peterson AC, Russell JD, Bailey DJ, Westphall MS, Coon JJ. Parallel reaction monitoring for high resolution and high mass accuracy quantitative, targeted proteomics. Mol Cell Proteomics. 2012;11:1475\u201388.","journal-title":"Mol Cell Proteomics"},{"key":"874_CR30","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1021\/acs.jproteome.0c00641","volume":"20","author":"A Petrera","year":"2020","unstructured":"Petrera A, von Toerne C, Behler J, Huth C, Thorand B, Hilgendorff A, Hauck SM. Multiplatform approach for plasma proteomics: complementarity of olink proximity extension assay technology to mass spectrometry-based protein profiling. J Proteome Res. 2020;20:751\u201362.","journal-title":"J Proteome Res"},{"key":"874_CR31","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.nbt.2011.11.016","volume":"29","author":"L Gold","year":"2012","unstructured":"Gold L, Walker JJ, Wilcox SK, Williams S. Advances in human proteomics at high scale with the SOMAscan proteomics platform. N Biotechnol. 2012;29:543\u20139.","journal-title":"N Biotechnol"},{"key":"874_CR32","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41592-020-0781-4","volume":"17","author":"J Li","year":"2020","unstructured":"Li J, Van Vranken JG, Pontano Vaites L, Schweppe DK, Huttlin EL, Etienne C, Nandhikonda P, Viner R, Robitaille AM, Thompson AH, et al. TMTpro reagents: a set of isobaric labeling mass tags enables simultaneous proteome-wide measurements across 16 samples. Nat Methods. 2020;17:399\u2013404.","journal-title":"Nat Methods"},{"key":"874_CR33","doi-asserted-by":"publisher","first-page":"5153","DOI":"10.1021\/acs.jproteome.4c00668","volume":"23","author":"NR Zuniga","year":"2024","unstructured":"Zuniga NR, Frost DC, Kuhn K, Shin M, Whitehouse RL, Wei T-Y, He Y, Dawson SL, Pike I, Bomgarden RD, et al. Achieving a 35-plex tandem mass tag reagent set through deuterium incorporation. J Proteome Res. 2024;23:5153\u201365.","journal-title":"J Proteome Res"},{"key":"874_CR34","doi-asserted-by":"publisher","first-page":"7162","DOI":"10.1021\/acs.analchem.0c00655","volume":"92","author":"Z Wang","year":"2020","unstructured":"Wang Z, Yu K, Tan H, Wu Z, Cho JH, Han X, Sun H, Beach TG, Peng J. 27-plex tandem mass tag mass spectrometry for profiling brain proteome in Alzheimer\u2019s disease. Anal Chem. 2020;92:7162\u201370.","journal-title":"Anal Chem"},{"key":"874_CR35","doi-asserted-by":"publisher","first-page":"e2100243","DOI":"10.1002\/pmic.202100243","volume":"22","author":"H Sun","year":"2022","unstructured":"Sun H, Poudel S, Vanderwall D, Lee DG, Li Y, Peng J. 29-plex tandem mass tag mass spectrometry enabling accurate quantification by interference correction. Proteomics. 2022;22:e2100243.","journal-title":"Proteomics"},{"key":"874_CR36","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1021\/acs.jproteome.0c00426","volume":"20","author":"D Liu","year":"2021","unstructured":"Liu D, Yang S, Kavdia K, Sifford JM, Wu Z, Xie B, Wang Z, Pagala VR, Wang H, Yu K, et al. Deep profiling of microgram-scale proteome by tandem mass tag mass spectrometry. J Proteome Res. 2021;20:337\u201345.","journal-title":"J Proteome Res"},{"key":"874_CR37","doi-asserted-by":"publisher","unstructured":"Wang Z, Kavdia K, Dey KK, Pagala VR, Kodali K, Liu D, Lee DG, Sun H, Chepyala SR, Cho JH, et al: High-throughput and deep-proteome profiling by 16-plex tandem mass tag labeling coupled with two-dimensional chromatography and mass spectrometry. J Vis Exp. 2020,162. https:\/\/doi.org\/10.3791\/61684.","DOI":"10.3791\/61684"},{"key":"874_CR38","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cell.2019.12.023","volume":"180","author":"DP Nusinow","year":"2020","unstructured":"Nusinow DP, Szpyt J, Ghandi M, Rose CM, McDonald ER 3rd, Kalocsay M, Jan\u00e9-Valbuena J, Gelfand E, Schweppe DK, Jedrychowski M, et al. Quantitative proteomics of the cancer cell line encyclopedia. Cell. 2020;180:387-402.e316.","journal-title":"Cell"},{"key":"874_CR39","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/nmeth.1714","volume":"8","author":"L Ting","year":"2011","unstructured":"Ting L, Rad R, Gygi SP, Haas W. MS3 eliminates ratio distortion in isobaric multiplexed quantitative proteomics. Nat Methods. 2011;8:937\u201340.","journal-title":"Nat Methods"},{"key":"874_CR40","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.1021\/acs.analchem.6b04415","volume":"89","author":"M Niu","year":"2017","unstructured":"Niu M, Cho J-H, Kodali K, Pagala V, High AA, Wang H, Wu Z, Li Y, Bi W, Zhang H, et al. Extensive peptide fractionation and y1 ion-based interference detection method for enabling accurate quantification by isobaric labeling and mass spectrometry. Anal Chem. 2017;89:2956\u201363.","journal-title":"Anal Chem"},{"key":"874_CR41","doi-asserted-by":"publisher","first-page":"100608","DOI":"10.1016\/j.mcpro.2023.100608","volume":"22","author":"M Zaman","year":"2023","unstructured":"Zaman M, Fu Y, Chen PC, Sun H, Yang S, Wu Z, Wang Z, Poudel S, Serrano GE, Beach TG, et al. Dissecting detergent-insoluble proteome in Alzheimer\u2019s disease by TMTc-corrected quantitative mass spectrometry. Mol Cell Proteomics. 2023;22:100608.","journal-title":"Mol Cell Proteomics"},{"key":"874_CR42","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1038\/s41587-023-02099-7","volume":"42","author":"UH Guzman","year":"2024","unstructured":"Guzman UH, Martinez-Val A, Ye Z, Damoc E, Arrey TN, Pashkova A, Renuse S, Denisov E, Petzoldt J, Peterson AC, et al. Ultra-fast label-free quantification and comprehensive proteome coverage with narrow-window data-independent acquisition. Nat Biotechnol. 2024;42:1855\u201366.","journal-title":"Nat Biotechnol"},{"key":"874_CR43","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1038\/s41592-020-00998-0","volume":"17","author":"F Meier","year":"2020","unstructured":"Meier F, Brunner A-D, Frank M, Ha A, Bludau I, Voytik E, Kaspar-Schoenefeld S, Lubeck M, Raether O, Bache N, et al. diaPASEF: parallel accumulation\u2013serial fragmentation combined with data-independent acquisition. Nat Methods. 2020;17:1229\u201336.","journal-title":"Nat Methods"},{"key":"874_CR44","doi-asserted-by":"publisher","first-page":"5378","DOI":"10.1021\/acs.jproteome.5b00932","volume":"14","author":"F Meier","year":"2015","unstructured":"Meier F, Beck S, Grassl N, Lubeck M, Park MA, Raether O, Mann M. Parallel Accumulation-Serial Fragmentation (PASEF): multiplying sequencing speed and sensitivity by synchronized scans in a trapped ion mobility device. J Proteome Res. 2015;14:5378\u201387.","journal-title":"J Proteome Res"},{"key":"874_CR45","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1074\/mcp.TIR118.000900","volume":"17","author":"F Meier","year":"2018","unstructured":"Meier F, Brunner AD, Koch S, Koch H, Lubeck M, Krause M, Goedecke N, Decker J, Kosinski T, Park MA, et al. Online Parallel Accumulation-Serial Fragmentation (PASEF) with a Novel Trapped Ion Mobility Mass Spectrometer. Mol Cell Proteomics. 2018;17:2534\u201345.","journal-title":"Mol Cell Proteomics"},{"key":"874_CR46","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1074\/mcp.TIR119.001906","volume":"19","author":"DB Bekker-Jensen","year":"2020","unstructured":"Bekker-Jensen DB, Mart\u00ednez-Val A, Steigerwald S, R\u00fcther P, Fort KL, Arrey TN, Harder A, Makarov A, Olsen JV. A compact quadrupole-orbitrap mass spectrometer with FAIMS interface improves proteome coverage in short LC gradients. Mol Cell Proteomics. 2020;19:716\u201329.","journal-title":"Mol Cell Proteomics"},{"key":"874_CR47","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1021\/acs.jproteome.2c00023","volume":"21","author":"Y Kawashima","year":"2022","unstructured":"Kawashima Y, Nagai H, Konno R, Ishikawa M, Nakajima D, Sato H, Nakamura R, Furuyashiki T, Ohara O. Single-shot 10K proteome approach: over 10,000 protein identifications by data-independent acquisition-based single-shot proteomics with ion mobility spectrometry. J Proteome Res. 2022;21:1418\u201327.","journal-title":"J Proteome Res"},{"key":"874_CR48","doi-asserted-by":"publisher","first-page":"5707","DOI":"10.1038\/s41467-024-49651-w","volume":"15","author":"C Ctortecka","year":"2024","unstructured":"Ctortecka C, Clark NM, Boyle BW, Seth A, Mani DR, Udeshi ND, Carr SA. Automated single-cell proteomics providing sufficient proteome depth to study complex biology beyond cell type classifications. Nat Commun. 2024;15:5707.","journal-title":"Nat Commun"},{"key":"874_CR49","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.1021\/acs.jproteome.3c00357","volume":"22","author":"LR Heil","year":"2023","unstructured":"Heil LR, Damoc E, Arrey TN, Pashkova A, Denisov E, Petzoldt J, Peterson AC, Hsu C, Searle BC, Shulman N, et al. Evaluating the performance of the astral mass analyzer for quantitative proteomics using data-independent acquisition. J Proteome Res. 2023;22:3290\u2013300.","journal-title":"J Proteome Res"},{"key":"874_CR50","doi-asserted-by":"publisher","first-page":"15656","DOI":"10.1021\/acs.analchem.3c02856","volume":"95","author":"HI Stewart","year":"2023","unstructured":"Stewart HI, Grinfeld D, Giannakopulos A, Petzoldt J, Shanley T, Garland M, Denisov E, Peterson AC, Damoc E, Zeller M, et al. Parallelized acquisition of orbitrap and astral analyzers enables high-throughput quantitative analysis. Anal Chem. 2023;95:15656\u201364.","journal-title":"Anal Chem"},{"key":"874_CR51","doi-asserted-by":"publisher","first-page":"3944","DOI":"10.1038\/s41467-022-31492-0","volume":"13","author":"V Demichev","year":"2022","unstructured":"Demichev V, Szyrwiel L, Yu F, Teo GC, Rosenberger G, Niewienda A, Ludwig D, Decker J, Kaspar-Schoenefeld S, Lilley KS, et al. dia-PASEF data analysis using FragPipe and DIA-NN for deep proteomics of low sample amounts. Nat Commun. 2022;13:3944.","journal-title":"Nat Commun"},{"key":"874_CR52","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41587-022-01389-w","volume":"41","author":"J Derks","year":"2023","unstructured":"Derks J, Leduc A, Wallmann G, Huffman RG, Willetts M, Khan S, Specht H, Ralser M, Demichev V, Slavov N. Increasing the throughput of sensitive proteomics by plexDIA. Nat Biotechnol. 2023;41:50\u20139.","journal-title":"Nat Biotechnol"},{"key":"874_CR53","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1021\/acs.jproteome.2c00721","volume":"22","author":"J Derks","year":"2023","unstructured":"Derks J, Slavov N. Strategies for increasing the depth and throughput of protein analysis by plexDIA. J Proteome Res. 2023;22:697\u2013705.","journal-title":"J Proteome Res"},{"key":"874_CR54","doi-asserted-by":"publisher","first-page":"e11503","DOI":"10.15252\/msb.202211503","volume":"19","author":"M Thielert","year":"2023","unstructured":"Thielert M, Itang EC, Ammar C, Rosenberger FA, Bludau I, Schweizer L, Nordmann TM, Skowronek P, Wahle M, Zeng WF. Robust dimethyl-based multiplex-DIA doubles single-cell proteome depth via a reference channel. Mol Syst Biol. 2023;19:e11503.","journal-title":"Mol Syst Biol"},{"key":"874_CR55","first-page":"e12179","volume":"13","author":"J Nilsson","year":"2021","unstructured":"Nilsson J, Gobom J, Sj\u00f6din S, Brinkmalm G, Ashton NJ, Svensson J, Johansson P, Portelius E, Zetterberg H, Blennow K, Brinkmalm A. Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer\u2019s disease. Alzheimers Dement. 2021;13:e12179.","journal-title":"Alzheimers Dement"},{"key":"874_CR56","first-page":"100544","volume":"5","author":"QQ Tao","year":"2024","unstructured":"Tao QQ, Cai X, Xue YY, Ge W, Yue L, Li XY, Lin RR, Peng GP, Jiang W, Li S, et al. Alzheimer\u2019s disease early diagnostic and staging biomarkers revealed by large-scale cerebrospinal fluid and serum proteomic profiling. Innovation. 2024;5:100544.","journal-title":"Innovation"},{"key":"874_CR57","doi-asserted-by":"publisher","first-page":"e055985","DOI":"10.1002\/alz.055985","volume":"17","author":"L Montoliu-Gaya","year":"2021","unstructured":"Montoliu-Gaya L, Ashton NJ, Benedet AL, Rodriguez JL, Brinkmalm G, Karikari TK, Kern S, Rosa-Neto P, Zetterberg H, Blennow K. Mass spectrometric measurement of six site-specific tau phosphorylations in CSF and blood of Alzheimer\u2019s disease patients. Alzheimers Dement. 2021;17:e055985.","journal-title":"Alzheimers Dement"},{"key":"874_CR58","doi-asserted-by":"publisher","first-page":"105157","DOI":"10.1016\/j.jprot.2024.105157","volume":"299","author":"Y Gao","year":"2024","unstructured":"Gao Y, Li J, Hu K, Wang S, Yang S, Ai Q, Yan J. Phosphoproteomic analysis of APP\/PS1 mice of Alzheimer\u2019s disease by DIA based mass spectrometry analysis with PRM verification. J Proteom. 2024;299:105157.","journal-title":"J Proteom"},{"key":"874_CR59","doi-asserted-by":"publisher","first-page":"103793","DOI":"10.1016\/j.ebiom.2021.103793","volume":"75","author":"E Camporesi","year":"2022","unstructured":"Camporesi E, Nilsson J, Vrillon A, Cognat E, Hourregue C, Zetterberg H, Blennow K, Becker B, Brinkmalm A, Paquet C, Brinkmalm G. Quantification of the trans-synaptic partners neurexin-neuroligin in CSF of neurodegenerative diseases by parallel reaction monitoring mass spectrometry. EBioMedicine. 2022;75:103793.","journal-title":"EBioMedicine"},{"key":"874_CR60","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.3233\/JAD-215119","volume":"85","author":"L Yang","year":"2022","unstructured":"Yang L, Xuan C, Yu C, Zheng P, Yan J. Diagnostic Model of Alzheimer\u2019s disease in the elderly based on protein and metabolic biomarkers. J Alzheimers Dis. 2022;85:1163\u201374.","journal-title":"J Alzheimers Dis"},{"key":"874_CR61","doi-asserted-by":"publisher","first-page":"e2000072","DOI":"10.1002\/prca.202000072","volume":"15","author":"J McKetney","year":"2021","unstructured":"McKetney J, Panyard DJ, Johnson SC, Carlsson CM, Engelman CD, Coon JJ. Pilot proteomic analysis of cerebrospinal fluid in Alzheimer\u2019s disease. Proteomics Clin Appl. 2021;15:e2000072.","journal-title":"Proteomics Clin Appl"},{"key":"874_CR62","doi-asserted-by":"publisher","first-page":"2100170","DOI":"10.1002\/pmic.202100170","volume":"22","author":"DE Haslam","year":"2022","unstructured":"Haslam DE, Li J, Dillon ST, Gu X, Cao Y, Zeleznik OA, Sasamoto N, Zhang X, Eliassen AH, Liang L. Stability and reproducibility of proteomic profiles in epidemiological studies: comparing the Olink and SOMAscan platforms. Proteomics. 2022;22:2100170.","journal-title":"Proteomics"},{"key":"874_CR63","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s43587-023-00565-0","volume":"4","author":"Y Guo","year":"2024","unstructured":"Guo Y, You J, Zhang Y, Liu WS, Huang YY, Zhang YR, Zhang W, Dong Q, Feng JF, Cheng W, Yu JT. Plasma proteomic profiles predict future dementia in healthy adults. Nat Aging. 2024;4:247\u201360.","journal-title":"Nat Aging"},{"key":"874_CR64","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3233\/JAD-220399","volume":"89","author":"J Timsina","year":"2022","unstructured":"Timsina J, Gomez-Fonseca D, Wang L, Do A, Western D, Alvarez I, Aguilar M, Pastor P, Henson RL, Herries E. Comparative analysis of Alzheimer\u2019s disease cerebrospinal fluid biomarkers measurement by multiplex SOMAscan platform and immunoassay-based approach 1. J Alzheimers Dis. 2022;89:193\u2013207.","journal-title":"J Alzheimers Dis"},{"key":"874_CR65","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13195-022-01113-5","volume":"14","author":"EB Dammer","year":"2022","unstructured":"Dammer EB, Ping L, Duong DM, Modeste ES, Seyfried NT, Lah JJ, Levey AI, Johnson ECB. Multi-platform proteomic analysis of Alzheimer\u2019s disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisome. Alzheimers Res Ther. 2022;14:174.","journal-title":"Alzheimers Res Ther"},{"key":"874_CR66","first-page":"10","volume":"2021","author":"L Gaetani","year":"1930","unstructured":"Gaetani L, Bellomo G, Parnetti L, Blennow K, Zetterberg H, Di Filippo M. Neuroinflammation and Alzheimer\u2019s disease: a machine learning approach to CSF proteomics. Cells. 1930;2021:10.","journal-title":"Cells"},{"key":"874_CR67","doi-asserted-by":"publisher","first-page":"100168","DOI":"10.1016\/j.mcpro.2021.100168","volume":"20","author":"L Wik","year":"2021","unstructured":"Wik L, Nordberg N, Broberg J, Bj\u00f6rkesten J, Assarsson E, Henriksson S, Grundberg I, Pettersson E, Westerberg C, Liljeroth E, et al. Proximity extension assay in combination with next-generation sequencing for high-throughput proteome-wide analysis. Mol Cell Proteomics. 2021;20:100168.","journal-title":"Mol Cell Proteomics"},{"key":"874_CR68","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/alz.12369","volume":"18","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Zhou X, Ip FC, Chan P, Chen Y, Lai NCH, Cheung K, Lo RMN, Tong EPS, Wong BWY, et al. Large-scale plasma proteomic profiling identifies a high-performance biomarker panel for Alzheimer\u2019s disease screening and staging. Alzheimers Dement. 2022;18:88\u2013102.","journal-title":"Alzheimers Dement"},{"key":"874_CR69","doi-asserted-by":"publisher","first-page":"19901","DOI":"10.1038\/s41598-024-71097-9","volume":"14","author":"SM Tokuoka","year":"2024","unstructured":"Tokuoka SM, Hamano F, Kobayashi A, Adachi S, Andou T, Natsume T, Oda Y. Plasma proteomics and lipidomics facilitate elucidation of the link between Alzheimer\u2019s disease development and vessel wall fragility. Sci Rep. 2024;14:19901.","journal-title":"Sci Rep"},{"key":"874_CR70","doi-asserted-by":"publisher","unstructured":"Rooney MR, Chen J, Ballantyne CM, Hoogeveen RC, Boerwinkle E, Yu B, Walker KA, Schlosser P, Selvin E, Chatterjee N, et al. Plasma proteomic comparisons change as coverage expands for SomaLogic and Olink. MedRxiv. 2024. https:\/\/doi.org\/10.1101\/2024.07.11.24310161.","DOI":"10.1101\/2024.07.11.24310161"},{"key":"874_CR71","doi-asserted-by":"crossref","unstructured":"Candia J. SomaScan Bioinformatics: Normalization, Quality Control, and Assessment of Pre-Analytical Variation. Methods Mol Biol. 2025;2929:107-27.","DOI":"10.1007\/978-1-0716-4595-6_9"},{"key":"874_CR72","doi-asserted-by":"publisher","first-page":"5531","DOI":"10.1021\/acs.jproteome.4c00667","volume":"23","author":"J Candia","year":"2024","unstructured":"Candia J, Fantoni G, Delgado-Peraza F, Shehadeh N, Tanaka T, Moaddel R, Walker KA, Ferrucci L. Variability of 7K and 11K somascan plasma proteomics assays. J Proteome Res. 2024;23:5531\u20139.","journal-title":"J Proteome Res"},{"key":"874_CR73","doi-asserted-by":"publisher","first-page":"eabm5164","DOI":"10.1126\/sciadv.abm5164","volume":"8","author":"DH Katz","year":"2022","unstructured":"Katz DH, Robbins JM, Deng S, Tahir UA, Bick AG, Pampana A, Yu Z, Ngo D, Benson MD, Chen Z-Z, et al. Proteomic profiling platforms head to head: Leveraging genetics and clinical traits to compare aptamer- and antibody-based methods. Sci Adv. 2022;8:eabm5164.","journal-title":"Sci Adv"},{"key":"874_CR74","doi-asserted-by":"publisher","first-page":"17147","DOI":"10.1038\/s41598-022-22116-0","volume":"12","author":"J Candia","year":"2022","unstructured":"Candia J, Daya GN, Tanaka T, Ferrucci L, Walker KA. Assessment of variability in the plasma 7k SomaScan proteomics assay. Sci Rep. 2022;12:17147.","journal-title":"Sci Rep"},{"key":"874_CR75","doi-asserted-by":"publisher","first-page":"100800","DOI":"10.1016\/j.mcpro.2024.100800","volume":"23","author":"K Frohlich","year":"2024","unstructured":"Frohlich K, Fahrner M, Brombacher E, Seredynska A, Maldacker M, Kreutz C, Schmidt A, Schilling O. Data-Independent acquisition: a milestone and prospect in clinical mass spectrometry-based proteomics. Mol Cell Proteomics. 2024;23:100800.","journal-title":"Mol Cell Proteomics"},{"key":"874_CR76","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1038\/s41592-024-02541-x","volume":"21","author":"TM Nordmann","year":"2024","unstructured":"Nordmann TM, Mund A, Mann M. A new understanding of tissue biology from MS-based proteomics at single-cell resolution. Nat Methods. 2024;21:2220\u20132.","journal-title":"Nat Methods"},{"key":"874_CR77","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41592-023-01785-3","volume":"20","author":"L Gatto","year":"2023","unstructured":"Gatto L, Aebersold R, Cox J, Demichev V, Derks J, Emmott E, Franks AM, Ivanov AR, Kelly RT, Khoury L, et al. Initial recommendations for performing, benchmarking and reporting single-cell proteomics experiments. Nat Methods. 2023;20:375\u201386.","journal-title":"Nat Methods"},{"key":"874_CR78","doi-asserted-by":"publisher","first-page":"5040","DOI":"10.1016\/j.cell.2022.11.021","volume":"185","author":"HS Bhatia","year":"2022","unstructured":"Bhatia HS, Brunner A-D, \u00d6zt\u00fcrk F, Kapoor S, Rong Z, Mai H, Thielert M, Ali M, Al-Maskari R, Paetzold JC. Spatial proteomics in three-dimensional intact specimens. Cell. 2022;185:5040-5058. e5019.","journal-title":"Cell"},{"key":"874_CR79","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/s41587-022-01302-5","volume":"40","author":"A Mund","year":"2022","unstructured":"Mund A, Coscia F, Kriston A, Hollandi R, Kovacs F, Brunner AD, Migh E, Schweizer L, Santos A, Bzorek M, et al. Deep visual proteomics defines single-cell identity and heterogeneity. Nat Biotechnol. 2022;40:1231\u201340.","journal-title":"Nat Biotechnol"},{"key":"874_CR80","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.cell.2024.12.023","volume":"188","author":"B Hu","year":"2025","unstructured":"Hu B, He R, Pang K, Wang G, Wang N, Zhu W, Sui X, Teng H, Liu T, Zhu J, et al. High-resolution spatially resolved proteomics of complex tissues based on microfluidics and transfer learning. Cell. 2025;188:734-748 e722.","journal-title":"Cell"},{"key":"874_CR81","doi-asserted-by":"publisher","first-page":"e2400545","DOI":"10.1002\/advs.202400545","volume":"11","author":"S Ghatak","year":"2024","unstructured":"Ghatak S, Diedrich JK, Talantova M, Bhadra N, Scott H, Sharma M, Albertolle M, Schork NJ, Yates JR 3rd, Lipton SA. Single-cell patch-clamp\/proteomics of human Alzheimer\u2019s disease iPSC-derived excitatory neurons versus isogenic wild-type controls suggests novel causation and therapeutic targets. Adv Sci. 2024;11:e2400545.","journal-title":"Adv Sci"},{"key":"874_CR82","doi-asserted-by":"publisher","first-page":"37061","DOI":"10.1074\/jbc.M403672200","volume":"279","author":"L Liao","year":"2004","unstructured":"Liao L, Cheng D, Wang J, Duong DM, Losik TG, Gearing M, Rees HD, Lah JJ, Levey AI, Peng J. Proteomic characterization of postmortem amyloid plaques isolated by laser capture microdissection. J Biol Chem. 2004;279:37061\u20138.","journal-title":"J Biol Chem"},{"key":"874_CR83","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3390\/proteomes6040046","volume":"6","author":"BM Lutz","year":"2018","unstructured":"Lutz BM, Peng J. Deep profiling of the aggregated proteome in alzheimer\u2019s disease: from pathology to disease mechanisms. Proteomes. 2018;6:46.","journal-title":"Proteomes"},{"key":"874_CR84","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41592-020-01010-5","volume":"18","author":"W Qin","year":"2021","unstructured":"Qin W, Cho KF, Cavanagh PE, Ting AY. Deciphering molecular interactions by proximity labeling. Nat Methods. 2021;18:133\u201343.","journal-title":"Nat Methods"},{"key":"874_CR85","doi-asserted-by":"publisher","first-page":"5325","DOI":"10.1021\/acs.analchem.1c05212","volume":"94","author":"X Sun","year":"2022","unstructured":"Sun X, Sun H, Han X, Chen PC, Jiao Y, Wu Z, Zhang X, Wang Z, Niu M, Yu K, et al. Deep single-cell-type proteome profiling of mouse brain by nonsurgical AAV-mediated proximity labeling. Anal Chem. 2022;94:5325\u201334.","journal-title":"Anal Chem"},{"key":"874_CR86","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-025-00817-0","volume":"20","author":"D Morderer","year":"2025","unstructured":"Morderer D, Wren MC, Liu F, Kouri N, Maistrenko A, Khalil B, Pobitzer N, Salemi MR, Phinney BS, Bu G, et al. Probe-dependent Proximity Profiling (ProPPr) uncovers similarities and differences in phospho-tau-associated proteomes between tauopathies. Mol Neurodegener. 2025;20:32.","journal-title":"Mol Neurodegener"},{"key":"874_CR87","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1038\/nbt.4016","volume":"35","author":"B Alvarez-Castelao","year":"2017","unstructured":"Alvarez-Castelao B, Schanzenbacher CT, Hanus C, Glock C, Tom Dieck S, Dorrbaum AR, Bartnik I, Nassim-Assir B, Ciirdaeva E, Mueller A, et al. Cell-type-specific metabolic labeling of nascent proteomes in vivo. Nat Biotechnol. 2017;35:1196\u2013201.","journal-title":"Nat Biotechnol"},{"key":"874_CR88","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1146\/annurev-physchem-061020-053416","volume":"72","author":"D Unsihuay","year":"2021","unstructured":"Unsihuay D, Mesa Sanchez D, Laskin J. Quantitative mass spectrometry imaging of biological systems. Annu Rev Phys Chem. 2021;72:307\u201329.","journal-title":"Annu Rev Phys Chem"},{"key":"874_CR89","doi-asserted-by":"publisher","first-page":"3802","DOI":"10.1038\/s41596-021-00556-8","volume":"16","author":"S Black","year":"2021","unstructured":"Black S, Phillips D, Hickey JW, Kennedy-Darling J, Venkataraaman VG, Samusik N, Goltsev Y, Sch\u00fcrch CM, Nolan GP. CODEX multiplexed tissue imaging with DNA-conjugated antibodies. Nat Protoc. 2021;16:3802\u201335.","journal-title":"Nat Protoc"},{"key":"874_CR90","doi-asserted-by":"publisher","first-page":"eaax5851","DOI":"10.1126\/sciadv.aax5851","volume":"5","author":"L Keren","year":"2019","unstructured":"Keren L, Bosse M, Thompson S, Risom T, Vijayaragavan K, McCaffrey E, Marquez D, Angoshtari R, Greenwald NF, Fienberg H. MIBI-TOF: a multiplexed imaging platform relates cellular phenotypes and tissue structure. Sci Adv. 2019;5:eaax5851.","journal-title":"Sci Adv"},{"key":"874_CR91","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jalz.2018.10.006","volume":"15","author":"F Xiong","year":"2019","unstructured":"Xiong F, Ge W, Ma C. Quantitative proteomics reveals distinct composition of amyloid plaques in Alzheimer\u2019s disease. Alzheimers Dement. 2019;15:429\u201340.","journal-title":"Alzheimers Dement"},{"key":"874_CR92","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1093\/brain\/awaa223","volume":"143","author":"E Drummond","year":"2020","unstructured":"Drummond E, Pires G, MacMurray C, Askenazi M, Nayak S, Bourdon M, Safar J, Ueberheide B, Wisniewski T. Phosphorylated tau interactome in the human Alzheimer\u2019s disease brain. Brain. 2020;143:2803\u201317.","journal-title":"Brain"},{"key":"874_CR93","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/alz.12089","volume":"16","author":"S Muraoka","year":"2020","unstructured":"Muraoka S, DeLeo AM, Sethi MK, Yukawa-Takamatsu K, Yang Z, Ko J, Hogan JD, Ruan Z, You Y, Wang Y, et al. Proteomic and biological profiling of extracellular vesicles from Alzheimer\u2019s disease human brain tissues. Alzheimers Dement. 2020;16:896\u2013907.","journal-title":"Alzheimers Dement"},{"key":"874_CR94","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.neurobiolaging.2021.04.012","volume":"105","author":"BC Carlyle","year":"2021","unstructured":"Carlyle BC, Kandigian SE, Kreuzer J, Das S, Trombetta BA, Kuo Y, Bennett DA, Schneider JA, Petyuk VA, Kitchen RR, et al. Synaptic proteins associated with cognitive performance and neuropathology in older humans revealed by multiplexed fractionated proteomics. Neurobiol Aging. 2021;105:99\u2013114.","journal-title":"Neurobiol Aging"},{"key":"874_CR95","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s42003-023-04961-5","volume":"6","author":"JM Krivinko","year":"2023","unstructured":"Krivinko JM, DeChellis-Marks MR, Zeng L, Fan P, Lopez OL, Ding Y, Wang L, Kofler J, MacDonald ML, Sweet RA. Targeting the post-synaptic proteome has therapeutic potential for psychosis in Alzheimer Disease. Commun Biol. 2023;6:598.","journal-title":"Commun Biol"},{"key":"874_CR96","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s40478-019-0847-7","volume":"7","author":"R Hesse","year":"2019","unstructured":"Hesse R, Hurtado ML, Jackson RJ, Eaton SL, Herrmann AG, Colom-Cadena M, Tzioras M, King D, Rose J, Tulloch J, et al. Comparative profiling of the synaptic proteome from Alzheimer\u2019s disease patients with focus on the APOE genotype. Acta Neuropathol Commun. 2019;7:214.","journal-title":"Acta Neuropathol Commun"},{"key":"874_CR97","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/s43587-022-00290-0","volume":"2","author":"PC Chen","year":"2022","unstructured":"Chen PC, Han X, Shaw TI, Fu Y, Sun H, Niu M, Wang Z, Jiao Y, Teubner BJW, Eddins D, et al. Alzheimer\u2019s disease-associated U1 snRNP splicing dysfunction causes neuronal hyperexcitability and cognitive impairment. Nat Aging. 2022;2:923\u201340.","journal-title":"Nat Aging"},{"key":"874_CR98","doi-asserted-by":"publisher","first-page":"16562","DOI":"10.1073\/pnas.1310249110","volume":"110","author":"B Bai","year":"2013","unstructured":"Bai B, Hales CM, Chen P-C, Gozal Y, Dammer EB, Fritz JJ, Wang X, Xia Q, Duong DM, Street C, et al. U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer\u2019s disease. Proc Natl Acad Sci USA. 2013;110:16562\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"874_CR99","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1016\/j.cell.2020.10.029","volume":"183","author":"H Wesseling","year":"2020","unstructured":"Wesseling H, Mair W, Kumar M, Schlaffner CN, Tang S, Beerepoot P, Fatou B, Guise AJ, Cheng L, Takeda S, et al. Tau PTM profiles identify patient heterogeneity and stages of Alzheimer\u2019s disease. Cell. 2020;183:1699-1713.e1613.","journal-title":"Cell"},{"key":"874_CR100","doi-asserted-by":"publisher","first-page":"eabc5802","DOI":"10.1126\/sciadv.abc5802","volume":"6","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Ma C, Chin LS, Li L. Integrative glycoproteomics reveals protein N-glycosylation aberrations and glycoproteomic network alterations in Alzheimer\u2019s disease. Sci Adv. 2020;6:eabc5802.","journal-title":"Sci Adv"},{"key":"874_CR101","doi-asserted-by":"publisher","first-page":"e1800108","DOI":"10.1002\/pmic.201800108","volume":"18","author":"MH Abreha","year":"2018","unstructured":"Abreha MH, Dammer EB, Ping L, Zhang T, Duong DM, Gearing M, Lah JJ, Levey AI, Seyfried NT. Quantitative analysis of the brain ubiquitylome in Alzheimer\u2019s disease. Proteomics. 2018;18:e1800108.","journal-title":"Proteomics"},{"key":"874_CR102","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s43587-021-00071-1","volume":"1","author":"N Morshed","year":"2021","unstructured":"Morshed N, Lee MJ, Rodriguez FH, Lauffenburger DA, Mastroeni D, White FM. Quantitative phosphoproteomics uncovers dysregulated kinase networks in Alzheimer\u2019s disease. Nat Aging. 2021;1:550\u201365.","journal-title":"Nat Aging"},{"key":"874_CR103","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41591-020-0815-6","volume":"26","author":"ECB Johnson","year":"2020","unstructured":"Johnson ECB, Dammer EB, Duong DM, Ping L, Zhou M, Yin L, Higginbotham LA, Guajardo A, White B, Troncoso JC, et al. Large-scale proteomic analysis of Alzheimer\u2019s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nat Med. 2020;26:769\u201380.","journal-title":"Nat Med"},{"key":"874_CR104","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M, Disterhoft J, Van Eldik L. Intraneuronal \u03b2-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J Neurosci. 2006;26:10129\u201340.","journal-title":"J Neurosci"},{"key":"874_CR105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1326-8-2","volume":"8","author":"WA Eimer","year":"2013","unstructured":"Eimer WA, Vassar R. Neuron loss in the 5XFAD mouse model of Alzheimer\u2019s disease correlates with intraneuronal A\u03b2 42 accumulation and caspase-3 activation. Mol Neurodegener. 2013;8:1\u201312.","journal-title":"Mol Neurodegener"},{"key":"874_CR106","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nn.3697","volume":"17","author":"T Saito","year":"2014","unstructured":"Saito T, Matsuba Y, Mihira N, Takano J, Nilsson P, Itohara S, Iwata N, Saido TC. Single app knock-in mouse models of Alzheimer\u2019s disease. Nat Neurosci. 2014;17:661\u20133.","journal-title":"Nat Neurosci"},{"key":"874_CR107","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","volume":"39","author":"S Oddo","year":"2003","unstructured":"Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM. Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles: intracellular A\u03b2 and synaptic dysfunction. Neuron. 2003;39:409\u201321.","journal-title":"Neuron"},{"key":"874_CR108","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s11011-021-00791-8","volume":"37","author":"S Ayyadevara","year":"2022","unstructured":"Ayyadevara S, Ganne A, Balasubramaniam M, Shmookler Reis RJ. Intrinsically disordered proteins identified in the aggregate proteome serve as biomarkers of neurodegeneration. Metab Brain Dis. 2022;37:147\u201352.","journal-title":"Metab Brain Dis"},{"key":"874_CR109","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00401-025-02844-z","volume":"149","author":"M Mart\u00e1-Ariza","year":"2025","unstructured":"Mart\u00e1-Ariza M, Leitner DF, Kanshin E, Suazo J, Giusti Pedrosa A, Thierry M, Lee EB, Devinsky O, Drummond E, Fortea J, et al. Comparison of the amyloid plaque proteome in down syndrome, early-onset Alzheimer\u2019s disease, and late-onset Alzheimer\u2019s disease. Acta Neuropathol. 2025;149:9.","journal-title":"Acta Neuropathol"},{"key":"874_CR110","doi-asserted-by":"publisher","unstructured":"Griffiths J, Schneegans E, Whitwell H, Qiu Z, Notman B, Cheung D, Willumsen N, Matthews PM, Grant SGN, Jackson JS. A synaptic-astrocytic proteomic signature associated with synaptopathy in Alzheimer\u2019s Disease. bioRxiv. 2025. https:\/\/doi.org\/10.1101\/2025.01.23.634408.","DOI":"10.1101\/2025.01.23.634408"},{"key":"874_CR111","doi-asserted-by":"publisher","first-page":"100819","DOI":"10.1016\/j.mcpro.2024.100819","volume":"23","author":"R Mohallem","year":"2024","unstructured":"Mohallem R, Schaser AJ, Aryal UK. Molecular signatures of neurodegenerative diseases identified by proteomic and phosphoproteomic analyses in aging mouse brain. Mol Cell Proteomics. 2024;23:100819.","journal-title":"Mol Cell Proteomics"},{"key":"874_CR112","doi-asserted-by":"publisher","first-page":"100433","DOI":"10.1016\/j.mcpro.2022.100433","volume":"21","author":"S Suttapitugsakul","year":"2022","unstructured":"Suttapitugsakul S, Stavenhagen K, Donskaya S, Bennett DA, Mealer RG, Seyfried NT, Cummings RD. Glycoproteomics landscape of asymptomatic and symptomatic human Alzheimer\u2019s disease brain. Mol Cell Proteomics. 2022;21:100433.","journal-title":"Mol Cell Proteomics"},{"key":"874_CR113","doi-asserted-by":"publisher","first-page":"eadk6911","DOI":"10.1126\/sciadv.adk6911","volume":"10","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Ma C, Chin LS, Pan S, Li L. Human brain glycoform coregulation network and glycan modification alterations in Alzheimer\u2019s disease. Sci Adv. 2024;10:eadk6911.","journal-title":"Sci Adv"},{"key":"874_CR114","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrn.2015.1","volume":"17","author":"Y Wang","year":"2016","unstructured":"Wang Y, Mandelkow E. Tau in physiology and pathology. Nat Rev Neurosci. 2016;17:5\u201321.","journal-title":"Nat Rev Neurosci"},{"issue":"633\u2013644","key":"874_CR115","first-page":"e612","volume":"180","author":"T Arakhamia","year":"2020","unstructured":"Arakhamia T, Lee CE, Carlomagno Y, Duong DM, Kundinger SR, Wang K, Williams D, DeTure M, Dickson DW, Cook CN. Posttranslational modifications mediate the structural diversity of tauopathy strains. Cell. 2020;180(633\u2013644):e612.","journal-title":"Cell"},{"key":"874_CR116","doi-asserted-by":"crossref","unstructured":"Poudel S, Vanderwall D, Yuan ZF, Wu Z, Peng J, Li Y. JUMPptm: Integrated software for sensitive identification of post-translational modifications and its application in Alzheimer's disease study. Proteomics. 2022;23:e2100369.","DOI":"10.1002\/pmic.202100369"},{"key":"874_CR117","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13024-023-00601-y","volume":"18","author":"K Wenger","year":"2023","unstructured":"Wenger K, Viode A, Schlaffner CN, van Zalm P, Cheng L, Dellovade T, Langlois X, Bannon A, Chang R, Connors TR, et al. Common mouse models of tauopathy reflect early but not late human disease. Mol Neurodegener. 2023;18:10.","journal-title":"Mol Neurodegener"},{"key":"874_CR118","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s00401-017-1691-0","volume":"133","author":"E Drummond","year":"2017","unstructured":"Drummond E, Nayak S, Faustin A, Pires G, Hickman RA, Askenazi M, Cohen M, Haldiman T, Kim C, Han X, et al. Proteomic differences in amyloid plaques in rapidly progressive and sporadic Alzheimer\u2019s disease. Acta Neuropathol. 2017;133:933\u201354.","journal-title":"Acta Neuropathol"},{"key":"874_CR119","doi-asserted-by":"publisher","first-page":"6021","DOI":"10.1073\/pnas.0501823102","volume":"102","author":"S Grau","year":"2005","unstructured":"Grau S, Baldi A, Bussani R, Tian X, Stefanescu R, Przybylski M, Richards P, Jones SA, Shridhar V, Clausen T. Implications of the serine protease HtrA1 in amyloid precursor protein processing. Proc Natl Acad Sci USA. 2005;102:6021\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"874_CR120","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1038\/s41467-024-46538-8","volume":"15","author":"S Chen","year":"2024","unstructured":"Chen S, Puri A, Bell B, Fritsche J, Palacios HH, Balch M, Sprunger ML, Howard MK, Ryan JJ, Haines JN, et al. HTRA1 disaggregates \u03b1-synuclein amyloid fibrils and converts them into non-toxic and seeding incompetent species. Nat Commun. 2024;15:2436.","journal-title":"Nat Commun"},{"key":"874_CR121","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/cdd.2008.191","volume":"16","author":"F Louren\u00e7o","year":"2009","unstructured":"Louren\u00e7o F, Galvan V, Fombonne J, Corset V, Llambi F, M\u00fcller U, Bredesen D, Mehlen P. Netrin-1 interacts with amyloid precursor protein and regulates amyloid-\u03b2 production. Cell Death Differ. 2009;16:655\u201363.","journal-title":"Cell Death Differ"},{"key":"874_CR122","doi-asserted-by":"publisher","first-page":"9271","DOI":"10.1007\/s11033-020-05996-1","volume":"47","author":"E Zamani","year":"2020","unstructured":"Zamani E, Parviz M, Roghani M, Hosseini M, Mohseni-Moghaddam P, Nikbakhtzadeh M. Netrin-1 protects the SH-SY5Y cells against amyloid beta neurotoxicity through NF-\u03baB\/Nrf2 dependent mechanism. Mol Biol Rep. 2020;47:9271\u20137.","journal-title":"Mol Biol Rep"},{"key":"874_CR123","doi-asserted-by":"publisher","first-page":"eabe4499","DOI":"10.1126\/sciadv.abe4499","volume":"7","author":"G Chen","year":"2021","unstructured":"Chen G, Kang SS, Wang Z, Ahn EH, Xia Y, Liu X, Sandoval IM, Manfredsson FP, Zhang Z, Ye K. Netrin-1 receptor UNC5C cleavage by active \u03b4-secretase enhances neurodegeneration, promoting Alzheimer\u2019s disease pathologies. Sci Adv. 2021;7:eabe4499.","journal-title":"Sci Adv"},{"key":"874_CR124","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s00401-024-02819-6","volume":"148","author":"K Balcomb","year":"2024","unstructured":"Balcomb K, Johnston C, Kavanagh T, Leitner D, Schneider J, Halliday G, Wisniewski T, Sunde M, Drummond E. SMOC1 colocalizes with Alzheimer\u2019s disease neuropathology and delays A\u03b2 aggregation. Acta Neuropathol. 2024;148:72.","journal-title":"Acta Neuropathol"},{"key":"874_CR125","doi-asserted-by":"publisher","first-page":"101669","DOI":"10.1016\/j.xcrm.2024.101669","volume":"5","author":"Y Levites","year":"2024","unstructured":"Levites Y, Dammer EB, Ran Y, Tsering W, Duong D, Abreha M, Gadhavi J, Lolo K, Trejo-Lopez J, Phillips J, et al. Integrative proteomics identifies a conserved A\u03b2 amyloid responsome, novel plaque proteins, and pathology modifiers in Alzheimer\u2019s disease. Cell Rep Med. 2024;5:101669.","journal-title":"Cell Rep Med"},{"key":"874_CR126","doi-asserted-by":"publisher","unstructured":"Zaman M, Yang S, Huang Y, Yarbro JM, Hao Y, Wang Z, Liu D, Harper KE, Soliman H, Hemphill A, et al. Midkine Attenuates A\u03b2 Fibril Assembly and Amyloid Plaque Formation. bioRxiv. 2025. https:\/\/doi.org\/10.1101\/2025.03.20.644383.","DOI":"10.1101\/2025.03.20.644383"},{"key":"874_CR127","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1006\/bbrc.1993.1406","volume":"192","author":"O Yasuhara","year":"1993","unstructured":"Yasuhara O, Muramatsu H, Kim S, Muramatsu T, Maruta H, McGeer P. Midkine, a novel neurotrophic factor, is present in senile plaques of Alzheimer disease. Biochem Biophys Res Commun. 1993;192:246\u201351.","journal-title":"Biochem Biophys Res Commun"},{"key":"874_CR128","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1755-7682-4-1","volume":"4","author":"H Muramatsul","year":"2011","unstructured":"Muramatsul H, Yokoi K, Chen L, Ichihara-Tanaka K, Kimura T, Muramatsu T. Midkine as a factor to counteract the deposition of amyloid \u03b2-peptide plaques: in vitro analysis and examination in knockout mice. Int Arch Med. 2011;4:1\u20139.","journal-title":"Int Arch Med"},{"key":"874_CR129","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1038\/s41593-019-0432-1","volume":"22","author":"P Esteve","year":"2019","unstructured":"Esteve P, Rueda-Carrasco J, In\u00e9s Mateo M, Martin-Bermejo MJ, Draffin J, Pereyra G, Sandon\u00eds \u00c1, Crespo I, Moreno I, Aso E, et al. Elevated levels of secreted-frizzled-related-protein 1 contribute to Alzheimer\u2019s disease pathogenesis. Nat Neurosci. 2019;22:1258\u201368.","journal-title":"Nat Neurosci"},{"key":"874_CR130","doi-asserted-by":"publisher","first-page":"e51696","DOI":"10.15252\/embr.202051696","volume":"22","author":"J Rueda-Carrasco","year":"2021","unstructured":"Rueda-Carrasco J, Martin-Bermejo MJ, Pereyra G, Mateo MI, Borroto A, Brosseron F, Kummer MP, Schwartz S, L\u00f3pez-Atalaya JP, Alarcon B, et al. SFRP1 modulates astrocyte-to-microglia crosstalk in acute and chronic neuroinflammation. EMBO Rep. 2021;22:e51696.","journal-title":"EMBO Rep"},{"key":"874_CR131","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.neuron.2022.03.004","volume":"110","author":"YA Martens","year":"2022","unstructured":"Martens YA, Zhao N, Liu C-C, Kanekiyo T, Yang AJ, Goate AM, Holtzman DM, Bu G. ApoE cascade hypothesis in the pathogenesis of Alzheimer\u2019s disease and related dementias. Neuron. 2022;110:1304\u201317.","journal-title":"Neuron"},{"key":"874_CR132","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1016\/j.immuni.2024.09.014","volume":"57","author":"S Kaji","year":"2024","unstructured":"Kaji S, Berghoff SA, Spieth L, Schlaphoff L, Sasmita AO, Vitale S, B\u00fcschgens L, Kedia S, Zirngibl M, Nazarenko T, et al. Apolipoprotein E aggregation in microglia initiates Alzheimer\u2019s disease pathology by seeding \u03b2-amyloidosis. Immunity. 2024;57:2651-2668.e2612.","journal-title":"Immunity"},{"key":"874_CR133","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s40478-018-0612-3","volume":"6","author":"M H\u00fcttenrauch","year":"2018","unstructured":"H\u00fcttenrauch M, Ogorek I, Klafki H, Otto M, Stadelmann C, Weggen S, Wiltfang J, Wirths O. Glycoprotein NMB: a novel Alzheimer\u2019s disease associated marker expressed in a subset of activated microglia. Acta Neuropathol Commun. 2018;6:108.","journal-title":"Acta Neuropathol Commun"},{"key":"874_CR134","doi-asserted-by":"publisher","first-page":"e0147208","DOI":"10.1371\/journal.pone.0147208","volume":"11","author":"AR Marques","year":"2016","unstructured":"Marques AR, Gabriel TL, Aten J, van Roomen CP, Ottenhoff R, Claessen N, Alfonso P, Ir\u00fan P, Giraldo P, Aerts JM. Gpnmb is a potential marker for the visceral pathology in Niemann-Pick type C disease. PLoS One. 2016;11:e0147208.","journal-title":"PLoS One"},{"key":"874_CR135","doi-asserted-by":"publisher","first-page":"115343","DOI":"10.1016\/j.celrep.2025.115343","volume":"44","author":"M Liu","year":"2025","unstructured":"Liu M, Zhu J, Zheng J, Han X, Jiang L, Tong X, Ke Y, Guo Z, Huang W, Cong J, et al. GPNMB and ATP6V1A interact to mediate microglia phagocytosis of multiple types of pathological particles. Cell Rep. 2025;44:115343.","journal-title":"Cell Rep"},{"key":"874_CR136","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3233\/JAD-240118","volume":"100","author":"Y Hu","year":"2024","unstructured":"Hu Y, Wang X, Zhao Z, Liu M, Ren X, Xian X, Liu C, Wang Q. The downregulation of ITGAX exacerbates amyloid-\u03b2 plaque deposition in Alzheimer\u2019s disease by increasing polarization of M1 microglia. J Alzheimers Dis. 2024;100:657\u201373.","journal-title":"J Alzheimers Dis"},{"key":"874_CR137","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13024-018-0254-8","volume":"13","author":"S Rangaraju","year":"2018","unstructured":"Rangaraju S, Dammer EB, Raza SA, Rathakrishnan P, Xiao H, Gao T, Duong DM, Pennington MW, Lah JJ, Seyfried NT, Levey AI. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer\u2019s disease. Mol Neurodegener. 2018;13:24.","journal-title":"Mol Neurodegener"},{"key":"874_CR138","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13024-022-00562-8","volume":"17","author":"B Zhu","year":"2022","unstructured":"Zhu B, Liu Y, Hwang S, Archuleta K, Huang H, Campos A, Murad R, Pi\u00f1a-Crespo J, Xu H, Huang TY. Trem2 deletion enhances tau dispersion and pathology through microglia exosomes. Mol Neurodegener. 2022;17:58.","journal-title":"Mol Neurodegener"},{"key":"874_CR139","doi-asserted-by":"publisher","first-page":"110883","DOI":"10.1016\/j.celrep.2022.110883","volume":"39","author":"R Dhandapani","year":"2022","unstructured":"Dhandapani R, Neri M, Bernhard M, Brzak I, Schweizer T, Rudin S, Joller S, Berth R, Kernen J, Neuhaus A, et al. Sustained Trem2 stabilization accelerates microglia heterogeneity and A\u03b2 pathology in a mouse model of Alzheimer\u2019s disease. Cell Rep. 2022;39:110883.","journal-title":"Cell Rep"},{"key":"874_CR140","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13195-024-01612-7","volume":"17","author":"N Cullell","year":"2025","unstructured":"Cullell N, Caruana G, Elias-Mas A, Delgado-Sanchez A, Artero C, Buongiorno MT, Almer\u00eda M, Ray NJ, Correa SAL, Krupinski J. Glymphatic system clearance and Alzheimer\u2019s disease risk: a CSF proteome-wide study. Alzheimers Res Ther. 2025;17:31.","journal-title":"Alzheimers Res Ther"},{"key":"874_CR141","doi-asserted-by":"crossref","unstructured":"Yadav H, Bakshi A, Anamika, Singh V, Paul P, Murugan NA, Maurya SK. Co-localization and co-expression of Olfml3 with Iba1 in brain of mice. J Neuroimmunol. 2024;394:578411","DOI":"10.1016\/j.jneuroim.2024.578411"},{"key":"874_CR142","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1136\/jclinpath-2020-206927","volume":"74","author":"MA Al Barashdi","year":"2021","unstructured":"Al Barashdi MA, Ali A, McMullin MF, Mills K. Protein tyrosine phosphatase receptor type C (PTPRC or CD45). J Clin Pathol. 2021;74:548\u201352.","journal-title":"J Clin Pathol"},{"key":"874_CR143","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.4049\/jimmunol.154.7.3333","volume":"154","author":"K Miyake","year":"1995","unstructured":"Miyake K, Yamashita Y, Ogata M, Sudo T, Kimoto M. RP105, a novel B cell surface molecule implicated in B cell activation, is a member of the leucine-rich repeat protein family. J Immunol. 1995;154:3333\u201340.","journal-title":"J Immunol"},{"key":"874_CR144","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/ni1198","volume":"6","author":"S Divanovic","year":"2005","unstructured":"Divanovic S, Trompette A, Atabani SF, Madan R, Golenbock DT, Visintin A, Finberg RW, Tarakhovsky A, Vogel SN, Belkaid Y, et al. Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105. Nat Immunol. 2005;6:571\u20138.","journal-title":"Nat Immunol"},{"key":"874_CR145","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.neuron.2025.01.023","volume":"113","author":"Y Chen","year":"2025","unstructured":"Chen Y, Zhou Y, Bai Y, Jia K, Zhang H, Chen Q, Song M, Dai Y, Shi J, Chen Z, et al. Macrophage-derived CTSS drives the age-dependent disruption of the blood-CSF barrier. Neuron. 2025;113:1082\u201397.","journal-title":"Neuron"},{"key":"874_CR146","doi-asserted-by":"publisher","first-page":"1394807","DOI":"10.3389\/fnagi.2024.1394807","volume":"16","author":"L Lin","year":"2024","unstructured":"Lin L, Wu Z, Luo H, Huang Y. Cathepsin-mediated regulation of alpha-synuclein in Parkinson\u2019s disease: a Mendelian randomization study. Front Aging Neurosci. 2024;16:1394807.","journal-title":"Front Aging Neurosci"},{"key":"874_CR147","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.cels.2016.11.006","volume":"4","author":"NT Seyfried","year":"2017","unstructured":"Seyfried NT, Dammer EB, Swarup V, Nandakumar D, Duong DM, Yin L, Deng Q, Nguyen T, Hales CM, Wingo T, et al. A multi-network approach identifies protein-specific co-expression in asymptomatic and symptomatic Alzheimer\u2019s disease. Cell Syst. 2017;4:60-72.e64.","journal-title":"Cell Syst"},{"key":"874_CR148","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S, Merry KM, Shi Q, Rosenthal A, Barres BA, et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science. 2016;352:712\u20136.","journal-title":"Science"},{"key":"874_CR149","doi-asserted-by":"publisher","first-page":"eaaf6295","DOI":"10.1126\/scitranslmed.aaf6295","volume":"9","author":"QQ Shi","year":"2017","unstructured":"Shi QQ, Chowdhury S, Ma R, Le KX, Hong S, Caldarone BJ, Stevens B, Lemere CA. Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP\/PS1 mice. Sci Transl Med. 2017;9:eaaf6295.","journal-title":"Sci Transl Med"},{"key":"874_CR150","doi-asserted-by":"publisher","first-page":"100542","DOI":"10.1016\/j.mcpro.2023.100542","volume":"22","author":"C Hurst","year":"2023","unstructured":"Hurst C, Pugh DA, Abreha MH, Duong DM, Dammer EB, Bennett DA, Herskowitz JH, Seyfried NT. Integrated proteomics to understand the role of neuritin (NRN1) as a mediator of cognitive resilience to Alzheimer\u2019s disease. Mol Cell Proteomics. 2023;22:100542.","journal-title":"Mol Cell Proteomics"},{"key":"874_CR151","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1016\/j.neurobiolaging.2012.12.026","volume":"34","author":"A Antonell","year":"2013","unstructured":"Antonell A, Llad\u00f3 A, Altirriba J, Botta-Orfila T, Balasa M, Fern\u00e1ndez M, Ferrer I, S\u00e1nchez-Valle R, Molinuevo JL. A preliminary study of the whole-genome expression profile of sporadic and monogenic early-onset Alzheimer\u2019s disease. Neurobiol Aging. 2013;34:1772\u20138.","journal-title":"Neurobiol Aging"},{"key":"874_CR152","doi-asserted-by":"publisher","first-page":"3942","DOI":"10.1038\/s41467-020-17405-z","volume":"11","author":"ND Beckmann","year":"2020","unstructured":"Beckmann ND, Lin W-J, Wang M, Cohain AT, Charney AW, Wang P, Ma W, Wang Y-C, Jiang C, Audrain M, et al. Multiscale causal networks identify VGF as a key regulator of Alzheimer\u2019s disease. Nat Commun. 2020;11:3942.","journal-title":"Nat Commun"},{"key":"874_CR153","doi-asserted-by":"publisher","first-page":"eadf0141","DOI":"10.1126\/scitranslmed.adf0141","volume":"15","author":"J Zhou","year":"2023","unstructured":"Zhou J, Wade SD, Graykowski D, Xiao MF, Zhao B, Giannini LAA, Hanson JE, van Swieten JC, Sheng M, Worley PF, Dejanovic B. The neuronal pentraxin Nptx2 regulates complement activity and restrains microglia-mediated synapse loss in neurodegeneration. Sci Transl Med. 2023;15:eadf0141.","journal-title":"Sci Transl Med"},{"key":"874_CR154","doi-asserted-by":"publisher","first-page":"101005","DOI":"10.1016\/j.xcrm.2023.101005","volume":"4","author":"PW van Zalm","year":"2023","unstructured":"van Zalm PW, Ahmed S, Fatou B, Schreiber R, Barnaby O, Boxer A, Zetterberg H, Steen JA, Steen H. Meta-analysis of published cerebrospinal fluid proteomics data identifies and validates metabolic enzyme panel as Alzheimer\u2019s disease biomarkers. Cell Rep Med. 2023;4:101005.","journal-title":"Cell Rep Med"},{"key":"874_CR155","doi-asserted-by":"publisher","first-page":"5635","DOI":"10.1038\/s41467-023-41122-y","volume":"14","author":"M Del Campo","year":"2023","unstructured":"Del Campo M, Vermunt L, Peeters CFW, Sieben A, Hok AHYS, Lleo A, Alcolea D, van Nee M, Engelborghs S, van Alphen JL, et al. CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer s disease. Nat Commun. 2023;14:5635.","journal-title":"Nat Commun"},{"key":"874_CR156","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13024-024-00767-z","volume":"19","author":"M Del Campo","year":"2024","unstructured":"Del Campo M, Quesada C, Vermunt L, Peeters CFW, Hok AHYS, Trieu C, Braber AD, Verberk IMW, Visser PJ, Tijms BM, et al. CSF proteins of inflammation, proteolysis and lipid transport define preclinical AD and progression to AD dementia in cognitively unimpaired individuals. Mol Neurodegener. 2024;19:82.","journal-title":"Mol Neurodegener"},{"key":"874_CR157","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1038\/s43587-022-00300-1","volume":"2","author":"M Del Campo","year":"2022","unstructured":"Del Campo M, Peeters CFW, Johnson ECB, Vermunt L, Hok AHYS, van Nee M, Chen-Plotkin A, Irwin DJ, Hu WT, Lah JJ, et al. CSF proteome profiling across the Alzheimer\u2019s disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels. Nat Aging. 2022;2:1040\u201353.","journal-title":"Nat Aging"},{"key":"874_CR158","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s43587-023-00550-7","volume":"4","author":"BM Tijms","year":"2024","unstructured":"Tijms BM, Vromen EM, Mjaavatten O, Holstege H, Reus LM, van der Lee S, Wesenhagen KEJ, Lorenzini L, Vermunt L, Venkatraghavan V, et al. Cerebrospinal fluid proteomics in patients with Alzheimer\u2019s disease reveals five molecular subtypes with distinct genetic risk profiles. Nat Aging. 2024;4:33\u201347.","journal-title":"Nat Aging"},{"key":"874_CR159","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","volume":"21","author":"CE Teunissen","year":"2022","unstructured":"Teunissen CE, Verberk IMW, Thijssen EH, Vermunt L, Hansson O, Zetterberg H, van der Flier WM, Mielke MM, Del Campo M. Blood-based biomarkers for Alzheimer\u2019s disease: towards clinical implementation. Lancet Neurol. 2022;21:66\u201377.","journal-title":"Lancet Neurol"},{"key":"874_CR160","doi-asserted-by":"publisher","first-page":"1380237","DOI":"10.3389\/fnagi.2024.1380237","volume":"16","author":"S Wang","year":"2024","unstructured":"Wang S, Xie S, Zheng Q, Zhang Z, Wang T, Zhang G. Biofluid biomarkers for Alzheimer\u2019s disease. Front Aging Neurosci. 2024;16:1380237.","journal-title":"Front Aging Neurosci"},{"key":"874_CR161","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41398-020-01137-1","volume":"11","author":"P Chatterjee","year":"2021","unstructured":"Chatterjee P, Pedrini S, Stoops E, Goozee K, Villemagne VL, Asih PR, Verberk IMW, Dave P, Taddei K, Sohrabi HR, et al. Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer\u2019s disease. Transl Psychiatry. 2021;11:27.","journal-title":"Transl Psychiatry"},{"key":"874_CR162","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/alz.12724","volume":"19","author":"P Chatterjee","year":"2023","unstructured":"Chatterjee P, Pedrini S, Doecke JD, Thota R, Villemagne VL, Dore V, Singh AK, Wang P, Rainey-Smith S, Fowler C, et al. Plasma Abeta42\/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer\u2019s disease continuum: a cross-sectional and longitudinal study in the AIBL cohort. Alzheimers Dement. 2023;19:1117\u201334.","journal-title":"Alzheimers Dement"},{"key":"874_CR163","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1002\/alz.12751","volume":"19","author":"S Palmqvist","year":"2023","unstructured":"Palmqvist S, Stomrud E, Cullen N, Janelidze S, Manuilova E, Jethwa A, Bittner T, Eichenlaub U, Suridjan I, Kollmorgen G, et al. An accurate fully automated panel of plasma biomarkers for Alzheimer\u2019s disease. Alzheimers Dement. 2023;19:1204\u201315.","journal-title":"Alzheimers Dement"},{"key":"874_CR164","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1093\/brain\/awac407","volume":"146","author":"F Gonzalez-Ortiz","year":"2023","unstructured":"Gonzalez-Ortiz F, Turton M, Kac PR, Smirnov D, Premi E, Ghidoni R, Benussi L, Cantoni V, Saraceno C, Rivolta J, et al. Brain-derived tau: a novel blood-based biomarker for Alzheimer\u2019s disease-type neurodegeneration. Brain. 2023;146:1152\u201365.","journal-title":"Brain"},{"key":"874_CR165","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/alz.12301","volume":"17","author":"AM Brickman","year":"2021","unstructured":"Brickman AM, Manly JJ, Honig LS, Sanchez D, Reyes-Dumeyer D, Lantigua RA, Lao PJ, Stern Y, Vonsattel JP, Teich AF, et al. Plasma p-tau181, p-tau217, and other blood-based Alzheimer\u2019s disease biomarkers in a multi-ethnic, community study. Alzheimers Dement. 2021;17:1353\u201364.","journal-title":"Alzheimers Dement"},{"key":"874_CR166","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13024-020-00384-6","volume":"15","author":"H Wang","year":"2020","unstructured":"Wang H, Dey KK, Chen PC, Li Y, Niu M, Cho JH, Wang X, Bai B, Jiao Y, Chepyala SR, et al. Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer\u2019s disease. Mol Neurodegener. 2020;15:43.","journal-title":"Mol Neurodegener"},{"key":"874_CR167","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12014-019-9237-1","volume":"16","author":"KK Dey","year":"2019","unstructured":"Dey KK, Wang H, Niu M, Bai B, Wang X, Li Y, Cho JH, Tan H, Mishra A, High AA, et al. Deep undepleted human serum proteome profiling toward biomarker discovery for Alzheimer\u2019s disease. Clin Proteomics. 2019;16:16.","journal-title":"Clin Proteomics"},{"key":"874_CR168","doi-asserted-by":"publisher","unstructured":"Lacar B, Ferdosi S, Alavi A, Stukalov A, Venkataraman GR, de Geus M, Dodge H, Wu CY, Kivisakk P, Das S, et al. Identification of novel biomarkers for Alzheimer's disease and related dementias using unbiased plasma proteomics. bioRxiv. 2024. https:\/\/doi.org\/10.1101\/2024.01.05.574446.","DOI":"10.1101\/2024.01.05.574446"},{"key":"874_CR169","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s13195-022-01133-1","volume":"14","author":"H Cai","year":"2022","unstructured":"Cai H, Pang Y, Wang Q, Qin W, Wei C, Li Y, Li T, Li F, Wang Q, Li Y, et al. Proteomic profiling of circulating plasma exosomes reveals novel biomarkers of Alzheimer\u2019s disease. Alzheimers Res Ther. 2022;14:181.","journal-title":"Alzheimers Res Ther"},{"key":"874_CR170","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1007\/s12035-022-02762-1","volume":"59","author":"T Soares Martins","year":"2022","unstructured":"Soares Martins T, Marcalo R, da Cruz ESCB, Trindade D, Catita J, Amado F, Melo T, Rosa IM, Vogelgsang J, Wiltfang J, et al. Novel exosome biomarker candidates for Alzheimer\u2019s disease unravelled through mass spectrometry analysis. Mol Neurobiol. 2022;59:2838\u201354.","journal-title":"Mol Neurobiol"},{"key":"874_CR171","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.3233\/JAD-210283","volume":"82","author":"M Francois","year":"2021","unstructured":"Francois M, Karpe A, Liu JW, Beale D, Hor M, Hecker J, Faunt J, Maddison J, Johns S, Doecke J, et al. Salivaomics as a potential tool for predicting Alzheimer\u2019s disease during the early stages of neurodegeneration. J Alzheimers Dis. 2021;82:1301\u201313.","journal-title":"J Alzheimers Dis"},{"key":"874_CR172","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3233\/ADR-210056","volume":"6","author":"E Eldem","year":"2022","unstructured":"Eldem E, Barve A, Sallin O, Foucras S, Annoni JM, Schmid AW, Alberi Auber L. Salivary proteomics identifies transthyretin as a biomarker of early dementia conversion. J Alzheimers Dis Rep. 2022;6:31\u201341.","journal-title":"J Alzheimers Dis Rep"},{"key":"874_CR173","doi-asserted-by":"publisher","first-page":"e2300202","DOI":"10.1002\/pmic.202300202","volume":"24","author":"C Contini","year":"2024","unstructured":"Contini C, Fadda L, Lai G, Masala C, Olianas A, Castagnola M, Messana I, Iavarone F, Bizzarro A, Masullo C, et al. A top-down proteomic approach reveals a salivary protein profile able to classify Parkinson\u2019s disease with respect to Alzheimer\u2019s disease patients and to healthy controls. Proteomics. 2024;24:e2300202.","journal-title":"Proteomics"},{"key":"874_CR174","doi-asserted-by":"publisher","first-page":"119857","DOI":"10.1016\/j.cca.2024.119857","volume":"562","author":"K Rajendran","year":"2024","unstructured":"Rajendran K, Krishnan UM. Biomarkers in Alzheimer\u2019s disease. Clin Chim Acta. 2024;562:119857.","journal-title":"Clin Chim Acta"},{"key":"874_CR175","doi-asserted-by":"publisher","first-page":"8153","DOI":"10.1038\/s41467-023-43995-5","volume":"14","author":"S Lee","year":"2023","unstructured":"Lee S, Kim E, Moon CE, Park C, Lim JW, Baek M, Shin MK, Ki J, Cho H, Ji YW, Haam S. Amplified fluorogenic immunoassay for early diagnosis and monitoring of Alzheimer\u2019s disease from tear fluid. Nat Commun. 2023;14:8153.","journal-title":"Nat Commun"},{"key":"874_CR176","doi-asserted-by":"publisher","unstructured":"Karkkainen V, Hannonen S, Rusanen M, Lehtola JM, Saari T, Uusitalo H, Leinonen V, Thiede B, Kaarniranta K, Koivisto AM, Utheim T. Tear fluid reflects the altered protein expressions of Alzheimer's disease patients in proteins involved in protein repair and clearance system or the regulation of cytoskeleton. J Alzheimers Dis. 2024. https:\/\/doi.org\/10.1177\/13872877241295315.","DOI":"10.1177\/13872877241295315"},{"key":"874_CR177","doi-asserted-by":"publisher","first-page":"e089992","DOI":"10.1002\/alz.089992","volume":"20","author":"C Yuan","year":"2024","unstructured":"Yuan C, Shen J, Huang Y, Wu M, Zheng Y, Guo T, Xu X. Tear proteomic signature associated with mild cognitive impairment and dementia: an exploratory analysis. Alzheimers Dement. 2024;20:e089992.","journal-title":"Alzheimers Dement"},{"key":"874_CR178","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12014-024-09462-z","volume":"21","author":"N Joshi","year":"2024","unstructured":"Joshi N, Garapati K, Ghose V, Kandasamy RK, Pandey A. Recent progress in mass spectrometry-based urinary proteomics. Clin Proteomics. 2024;21:14.","journal-title":"Clin Proteomics"},{"key":"874_CR179","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s13195-023-01324-4","volume":"15","author":"Y Wang","year":"2023","unstructured":"Wang Y, Sun Y, Wang Y, Jia S, Qiao Y, Zhou Z, Shao W, Zhang X, Guo J, Zhang B, et al. Identification of novel diagnostic panel for mild cognitive impairment and Alzheimer\u2019s disease: findings based on urine proteomics and machine learning. Alzheimers Res Ther. 2023;15:191.","journal-title":"Alzheimers Res Ther"},{"key":"874_CR180","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/nbt1235","volume":"24","author":"N Rifai","year":"2006","unstructured":"Rifai N, Gillette MA, Carr SA. Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol. 2006;24:971\u201383.","journal-title":"Nat Biotechnol"},{"key":"874_CR181","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1038\/s41593-021-00886-6","volume":"24","author":"C Yang","year":"2021","unstructured":"Yang C, Farias FHG, Ibanez L, Suhy A, Sadler B, Fernandez MV, Wang F, Bradley JL, Eiffert B, Bahena JA, et al. Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disorders. Nat Neurosci. 2021;24:1302\u201312.","journal-title":"Nat Neurosci"},{"key":"874_CR182","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","volume":"53","author":"E Ferkingstad","year":"2021","unstructured":"Ferkingstad E, Sulem P, Atlason BA, Sveinbjornsson G, Magnusson MI, Styrmisdottir EL, Gunnarsdottir K, Helgason A, Oddsson A, Halldorsson BV, et al. Large-scale integration of the plasma proteome with genetics and disease. Nat Genet. 2021;53:1712\u201321.","journal-title":"Nat Genet"},{"key":"874_CR183","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41586-023-06563-x","volume":"622","author":"GH Eldjarn","year":"2023","unstructured":"Eldjarn GH, Ferkingstad E, Lund SH, Helgason H, Magnusson OT, Gunnarsdottir K, Olafsdottir TA, Halldorsson BV, Olason PI, Zink F, et al. Large-scale plasma proteomics comparisons through genetics and disease associations. Nature. 2023;622:348\u201358.","journal-title":"Nature"},{"key":"874_CR184","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41586-018-0175-2","volume":"558","author":"BB Sun","year":"2018","unstructured":"Sun BB, Maranville JC, Peters JE, Stacey D, Staley JR, Blackshaw J, Burgess S, Jiang T, Paige E, Surendran P, et al. Genomic atlas of the human plasma proteome. Nature. 2018;558:73\u20139.","journal-title":"Nature"},{"key":"874_CR185","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"BB Sun","year":"2023","unstructured":"Sun BB, Chiou J, Traylor M, Benner C, Hsu YH, Richardson TG, Surendran P, Mahajan A, Robins C, Vasquez-Grinnell SG, et al. Plasma proteomic associations with genetics and health in the UK Biobank. Nature. 2023;622:329\u201338.","journal-title":"Nature"},{"key":"874_CR186","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature10098","volume":"473","author":"B Schwanh\u00e4usser","year":"2011","unstructured":"Schwanh\u00e4usser B, Busse D, Li N, Dittmar G, Schuchhardt J, Wolf J, Chen W, Selbach M. Global quantification of mammalian gene expression control. Nature. 2011;473:337\u201342.","journal-title":"Nature"},{"key":"874_CR187","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1126\/science.1260793","volume":"347","author":"A Battle","year":"2015","unstructured":"Battle A, Khan Z, Wang SH, Mitrano A, Ford MJ, Pritchard JK, Gilad Y. Genomic variation. Impact of regulatory variation from RNA to protein. Science. 2015;347:664\u20137.","journal-title":"Science"},{"key":"874_CR188","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2016.03.014","volume":"165","author":"Y Liu","year":"2016","unstructured":"Liu Y, Beyer A, Aebersold R. On the dependency of cellular protein levels on mRNA abundance. Cell. 2016;165:535\u201350.","journal-title":"Cell"},{"key":"874_CR189","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41588-020-00773-z","volume":"53","author":"AP Wingo","year":"2021","unstructured":"Wingo AP, Liu Y, Gerasimov ES, Gockley J, Logsdon BA, Duong DM, Dammer EB, Robins C, Beach TG, Reiman EM, et al. Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer\u2019s disease pathogenesis. Nat Genet. 2021;53:143\u20136.","journal-title":"Nat Genet"},{"key":"874_CR190","doi-asserted-by":"publisher","first-page":"eabq5923","DOI":"10.1126\/scitranslmed.abq5923","volume":"15","author":"YJ Sung","year":"2023","unstructured":"Sung YJ, Yang C, Norton J, Johnson M, Fagan A, Bateman RJ, Perrin RJ, Morris JC, Farlow MR, Chhatwal JP, et al. Proteomics of brain, CSF, and plasma identifies molecular signatures for distinguishing sporadic and genetic Alzheimer\u2019s disease. Sci Transl Med. 2023;15:eabq5923.","journal-title":"Sci Transl Med"},{"key":"874_CR191","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1038\/s41588-024-01972-8","volume":"56","author":"D Western","year":"2024","unstructured":"Western D, Timsina J, Wang L, Wang C, Yang C, Phillips B, Wang Y, Liu M, Ali M, Beric A, et al. Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and implicates causal proteins for Alzheimer\u2019s disease. Nat Genet. 2024;56:2672\u201384.","journal-title":"Nat Genet"},{"key":"874_CR192","doi-asserted-by":"publisher","first-page":"eaau2291","DOI":"10.1126\/scitranslmed.aau2291","volume":"11","author":"Y Deming","year":"2019","unstructured":"Deming Y, Filipello F, Cignarella F, Cantoni C, Hsu S, Mikesell R, Li Z, Del-Aguila JL, Dube U, Farias FG, et al. The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer\u2019s disease risk. Sci Transl Med. 2019;11:eaau2291.","journal-title":"Sci Transl Med"},{"key":"874_CR193","doi-asserted-by":"publisher","unstructured":"Hu T, Liu Q, Dai Q, Parrish RL, Buchman AS, Tasaki S, Seyfried NT, Wang Y, Bennett DA, De Jager PL, et al. Proteome-wide association studies using summary pQTL data of three tissues identified 30 risk genes of Alzheimer's disease dementia. medRxiv. 2024. https:\/\/doi.org\/10.1101\/2024.03.28.24305044.","DOI":"10.1101\/2024.03.28.24305044"},{"key":"874_CR194","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1016\/j.cell.2025.02.021","volume":"188","author":"W Li","year":"2025","unstructured":"Li W, Dasgupta A, Yang K, Wang S, Hemandhar-Kumar N, Chepyala SR, Yarbro JM, Hu Z, Salovska B, Fornasiero EF, et al. Turnover atlas of proteome and phosphoproteome across mouse tissues and brain regions. Cell. 2025;188:2267\u201387.","journal-title":"Cell"},{"key":"874_CR195","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-020-00760-w","volume":"13","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Fang J, Bekris LM, Kim YH, Pieper AA, Leverenz JB, Cummings J, Cheng F. AlzGPS: a genome-wide positioning systems platform to catalyze multi-omics for Alzheimer\u2019s drug discovery. Alzheimers Res Ther. 2021;13:1\u201313.","journal-title":"Alzheimers Res Ther"},{"key":"874_CR196","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/s41597-024-03485-9","volume":"11","author":"MV Fernandez","year":"2024","unstructured":"Fernandez MV, Liu M, Beric A, Johnson M, Cetin A, Patel M, Budde J, Kohlfeld P, Bergmann K, Lowery J. Genetic and multi-omic resources for Alzheimer disease and related dementia from the knight Alzheimer disease research center. Sci data. 2024;11:768.","journal-title":"Sci data"},{"key":"874_CR197","doi-asserted-by":"publisher","first-page":"eabo6764","DOI":"10.1126\/sciadv.abo6764","volume":"8","author":"Y Iturria-Medina","year":"2022","unstructured":"Iturria-Medina Y, Adewale Q, Khan AF, Ducharme S, Rosa-Neto P, O\u2019Donnell K, Petyuk VA, Gauthier S, De Jager PL, Breitner J. Unified epigenomic, transcriptomic, proteomic, and metabolomic taxonomy of Alzheimer\u2019s disease progression and heterogeneity. Sci Adv. 2022;8:eabo6764.","journal-title":"Sci Adv"},{"key":"874_CR198","doi-asserted-by":"publisher","first-page":"e3002607","DOI":"10.1371\/journal.pbio.3002607","volume":"22","author":"AM Eteleeb","year":"2024","unstructured":"Eteleeb AM, Novotny BC, Tarraga CS, Sohn C, Dhungel E, Brase L, Nallapu A, Buss J, Farias F, Bergmann K. Brain high-throughput multi-omics data reveal molecular heterogeneity in Alzheimer\u2019s disease. PLoS Biol. 2024;22:e3002607.","journal-title":"PLoS Biol"},{"key":"874_CR199","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.cels.2021.06.006","volume":"12","author":"M Mann","year":"2021","unstructured":"Mann M, Kumar C, Zeng W-F, Strauss MT. Artificial intelligence for proteomics and biomarker discovery. Cell Syst. 2021;12:759\u201370.","journal-title":"Cell Syst"},{"key":"874_CR200","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.cels.2021.05.016","volume":"12","author":"Y Ji","year":"2021","unstructured":"Ji Y, Lotfollahi M, Wolf FA, Theis FJ. Machine learning for perturbational single-cell omics. Cell Syst. 2021;12:522\u201337.","journal-title":"Cell Syst"},{"key":"874_CR201","doi-asserted-by":"publisher","first-page":"4488","DOI":"10.1016\/j.cell.2024.07.040","volume":"187","author":"L Liu","year":"2024","unstructured":"Liu L, Chen A, Li Y, Mulder J, Heyn H, Xu X. Spatiotemporal omics for biology and medicine. Cell. 2024;187:4488\u2013519.","journal-title":"Cell"},{"key":"874_CR202","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/ansa.202000152","volume":"2","author":"C Ctortecka","year":"2021","unstructured":"Ctortecka C, Mechtler K. The rise of single-cell proteomics. Anal Sci Adv. 2021;2:84\u201394.","journal-title":"Anal Sci Adv"},{"key":"874_CR203","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s43586-021-00029-y","volume":"1","author":"JA Christopher","year":"2021","unstructured":"Christopher JA, Stadler C, Martin CE, Morgenstern M, Pan Y, Betsinger CN, Rattray DG, Mahdessian D, Gingras A-C, Warscheid B. Subcellular proteomics. Nat Rev Methods Primers. 2021;1:32.","journal-title":"Nat Rev Methods Primers"},{"key":"874_CR204","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/s41586-024-07606-7","volume":"632","author":"H Mathys","year":"2024","unstructured":"Mathys H, Boix CA, Akay LA, Xia Z, Davila-Velderrain J, Ng AP, Jiang X, Abdelhady G, Galani K, Mantero J. Single-cell multiregion dissection of Alzheimer\u2019s disease. Nature. 2024;632:858\u201368.","journal-title":"Nature"},{"key":"874_CR205","doi-asserted-by":"publisher","first-page":"107739","DOI":"10.1016\/j.biotechadv.2021.107739","volume":"49","author":"PS Reel","year":"2021","unstructured":"Reel PS, Reel S, Pearson E, Trucco E, Jefferson E. Using machine learning approaches for multi-omics data analysis: a review. Biotechnol Adv. 2021;49:107739.","journal-title":"Biotechnol Adv"},{"key":"874_CR206","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/s43587-022-00252-6","volume":"2","author":"AA Cohen","year":"2022","unstructured":"Cohen AA, Ferrucci L, F\u00fcl\u00f6p T, Gravel D, Hao N, Kriete A, Levine ME, Lipsitz LA, Olde Rikkert MG, Rutenberg A. A complex systems approach to aging biology. Nat Aging. 2022;2:580\u201391.","journal-title":"Nat Aging"},{"key":"874_CR207","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41568-023-00657-4","volume":"24","author":"N de Souza","year":"2024","unstructured":"de Souza N, Zhao S, Bodenmiller B. Multiplex protein imaging in tumour biology. Nat Rev Cancer. 2024;24:171\u201391.","journal-title":"Nat Rev Cancer"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-025-00874-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-025-00874-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-025-00874-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T10:55:48Z","timestamp":1757242548000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-025-00874-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,14]]},"references-count":207,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["874"],"URL":"https:\/\/doi.org\/10.1186\/s13024-025-00874-5","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,14]]},"assertion":[{"value":"27 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have approved the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"83"}}